Eligibility NSAID-induced Gastroduodenal Injury NCT00597818

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient is more than 40 and less than 70 years of age.
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
patient has confirmed osteoarthritis (oa) and/or rheumatoid arthritis (ra) and could benefit from nsaid therapy.
Beskrivning

Osteoarthritis | Rheumatoid Arthritis | Benefit Due to NSAID treatment

Datatyp

boolean

Alias
UMLS CUI [1]
C0029408
UMLS CUI [2]
C0003873
UMLS CUI [3,1]
C0814225
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C0746950
no current gastrointestinal h. pylori infection.
Beskrivning

Helicobacter pylori gastrointestinal tract infection Absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0585625
UMLS CUI [1,2]
C0332197
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
known allergy or hypersensitivity to nsaids, or has any other contraindicated condition(s) to nsaid therapy.
Beskrivning

Allergy to nonsteroidal anti-inflammatory agents | Medical contraindication NSAID treatment

Datatyp

boolean

Alias
UMLS CUI [1]
C0746949
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0746950
patient has undergone a gastrointestinal or abdominal surgical procedure within 90 days prior to the screening visit, or has had a bowel resection at any time.
Beskrivning

Gastrointestinal Surgical Procedure | Abdominal operation | Bowel resection

Datatyp

boolean

Alias
UMLS CUI [1]
C0524722
UMLS CUI [2]
C0198482
UMLS CUI [3]
C0741614
medical history includes prior or active gi complications and/or disorders, including but not limited to barrett's esophagus, erosive esophagitis, esophageal stricture or ring, gastric obstruction, irritable bowel syndrome (ibs), or inflammatory bowel disease (ibd).
Beskrivning

Gastrointestinal complication | Gastrointestinal Diseases | Barrett Esophagus | Erosive esophagitis | Esophageal Stenosis | Esophageal ring | Obstruction gastric | Irritable Bowel Syndrome | Inflammatory Bowel Disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0161819
UMLS CUI [2]
C0017178
UMLS CUI [3]
C0004763
UMLS CUI [4]
C0267055
UMLS CUI [5]
C0014866
UMLS CUI [6]
C0267081
UMLS CUI [7]
C0149700
UMLS CUI [8]
C0022104
UMLS CUI [9]
C0021390
active symptomatic peptic ulcer disease or gi bleeding.
Beskrivning

Peptic Ulcer Symptomatic | Gastrointestinal Hemorrhage

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0030920
UMLS CUI [1,2]
C0231220
UMLS CUI [2]
C0017181
patient has received cobiprostone (spi-8811; ru-8811) or amitiza (lubiprostone, spi-0211, or ru-0211) at any time prior to participation in this study.
Beskrivning

cobiprostone | SPI-8811 | Amitiza | lubiprostone | SPI 0211 | RU 0211

Datatyp

boolean

Alias
UMLS CUI [1]
C2699393
UMLS CUI [2]
C2703103
UMLS CUI [3]
C1699150
UMLS CUI [4]
C1684405
UMLS CUI [5]
C1681887
UMLS CUI [6]
C1683269

Similar models

Eligibility NSAID-induced Gastroduodenal Injury NCT00597818

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patient is more than 40 and less than 70 years of age.
boolean
C0001779 (UMLS CUI [1])
Osteoarthritis | Rheumatoid Arthritis | Benefit Due to NSAID treatment
Item
patient has confirmed osteoarthritis (oa) and/or rheumatoid arthritis (ra) and could benefit from nsaid therapy.
boolean
C0029408 (UMLS CUI [1])
C0003873 (UMLS CUI [2])
C0814225 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0746950 (UMLS CUI [3,3])
Helicobacter pylori gastrointestinal tract infection Absent
Item
no current gastrointestinal h. pylori infection.
boolean
C0585625 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Allergy to nonsteroidal anti-inflammatory agents | Medical contraindication NSAID treatment
Item
known allergy or hypersensitivity to nsaids, or has any other contraindicated condition(s) to nsaid therapy.
boolean
C0746949 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0746950 (UMLS CUI [2,2])
Gastrointestinal Surgical Procedure | Abdominal operation | Bowel resection
Item
patient has undergone a gastrointestinal or abdominal surgical procedure within 90 days prior to the screening visit, or has had a bowel resection at any time.
boolean
C0524722 (UMLS CUI [1])
C0198482 (UMLS CUI [2])
C0741614 (UMLS CUI [3])
Gastrointestinal complication | Gastrointestinal Diseases | Barrett Esophagus | Erosive esophagitis | Esophageal Stenosis | Esophageal ring | Obstruction gastric | Irritable Bowel Syndrome | Inflammatory Bowel Disease
Item
medical history includes prior or active gi complications and/or disorders, including but not limited to barrett's esophagus, erosive esophagitis, esophageal stricture or ring, gastric obstruction, irritable bowel syndrome (ibs), or inflammatory bowel disease (ibd).
boolean
C0161819 (UMLS CUI [1])
C0017178 (UMLS CUI [2])
C0004763 (UMLS CUI [3])
C0267055 (UMLS CUI [4])
C0014866 (UMLS CUI [5])
C0267081 (UMLS CUI [6])
C0149700 (UMLS CUI [7])
C0022104 (UMLS CUI [8])
C0021390 (UMLS CUI [9])
Peptic Ulcer Symptomatic | Gastrointestinal Hemorrhage
Item
active symptomatic peptic ulcer disease or gi bleeding.
boolean
C0030920 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0017181 (UMLS CUI [2])
cobiprostone | SPI-8811 | Amitiza | lubiprostone | SPI 0211 | RU 0211
Item
patient has received cobiprostone (spi-8811; ru-8811) or amitiza (lubiprostone, spi-0211, or ru-0211) at any time prior to participation in this study.
boolean
C2699393 (UMLS CUI [1])
C2703103 (UMLS CUI [2])
C1699150 (UMLS CUI [3])
C1684405 (UMLS CUI [4])
C1681887 (UMLS CUI [5])
C1683269 (UMLS CUI [6])